For meetings and deliveries:
12 Veterans Square
1st Floor Left
Media, PA 19063 U.S.A.
P.O. Box 209
Swarthmore, PA 19081-0209 U.S.A.
Phone: (610) 892-9942
Twitter: @TechLaw_Elman and @ElmanTechNews
eFax: (925) 226-4995
Two hearings have been scheduled by the US PTO on the effect of patents for Genetic Testing, to support the study that the PTO is mandated by the Leahy-Smith America Invents Act (“AIA”) to generate for Congress.
The first of the hearings is today. It will be broadcast via the Web.
The second of the hearings will be March 9 in San Diego. My colleague Prof. Chris Holman, incoming Executive Editor of Biotechnology Law Report, is scheduled to testify at that hearing.
Each of these agendas provides the logon information for the web broadcasts of the hearings.
- Supreme Court, snowed by ACLU smear campaign, resurrects archaic requirement of “invention” as a test of patent eligibility.
- State of Vermont Declares War on “Patent Trolls”
- Are Human Genes Patentable?—The Experts Weigh In
- Spark Your Creativity: participate online in Tina Seelig’s MOOC via Stanford’s Venture Lab
- Patentability: “non-obviousness” and “common sense”
- PTAB Invalidates Patent Despite Settlement
- Patent Term Adjustment And Double Patenting
- An Even Faster Track in E.D. Texas: Accelerated Damages Discovery in Patent Cases
- Trademark Infringement Suit Transferred from D.C. to Florida on Defendant’s Rule 12(b)(3) Motion to Dismiss for Improper Venue
- Lighting Ballast Control v. Philips Electronics North America: Federal Circuit Reaffirms De Novo Appellate Review for District Court Claim Constructions
- Court Says List All Products in All Amended Infringement Contentions or Face Dismissal.